Research On Global Markets
Syndicated Market Research Report
Owing to its unique ability of detect the presence of, severity, and exact location of chronic diseases and tumors, multiplex biomarker imaging techniques are witnessing widespread adoption. Not only for oncology studies or drug safety applications, multiplex biomarker imaging techniques are gradually making its presence felt in the diagnosis of Alzheimer’s disease. Alzheimer’s disease is currently ranked amongst the top 10 causes of death in the U.S. and comes across as the only disease on the list that cannot be prevented, cured, or even slowed. The current diagnosis of Alzheimer’s disease involves recording mild cognitive impairment (MCI). However, it is a considerably time-consuming process and by the time a detectable amount of MCI is demonstrated, Alzheimer’s causes significant amount damage to the human brain. To address the significant challenges of delayed diagnosis, multiple biomarkers are being examined for their ability to detect early stages and interventional measures for Alzheimer’s. This expansion of multiplex biomarkers to a new target disease bodes well for the growth of the global multiplex biomarker imaging market. Several studies are being conducted to adopt the mechanism of deploying multiple biomarkers techniques to cross-analyze, diagnose, and predict Alzheimer’s. Genetic, imaging, CSF, and blood-based biomarkers are combined to better understand and predict the utility of biomarkers for Alzheimer’s. Perhaps the biggest advantage of adopting multiplex biomarker techniques for Alzheimer’s disease is in its compelling ability to diagnose the disease at the earliest stage. The benefit of detecting Alzheimer’s early is that it allows patients as well as their families to plan for the future and get better access to medical and palliative care and services. Global multiplex biomarker imaging market research shows that early diagnosis allows patients to participate in clinical trials to better understand the extent of the disease and, lead to developing a cure for the disease. Further, large pharmaceuticals have already started exploring biomarker techniques that involves cross-analyzing CSF and imaging biomarkers to better diagnose Alzheimer’s. Our related post: An overview of The Global Multiplex Biomarker Imaging Market Why is The Global Multiplex Biomarker Imaging Market Flourishing? What is Provoking Global Multiplex Biomarker Imaging Market Growth?
0 Comments
Leave a Reply. |
Archives
December 2019
Categories
All
|